WW International Adds Novo Nordisk's Wegovy to Weight Management Platform

MT Newswires Live
01/05

WW International (WW) said Monday it is incorporating the newly US Food and Drug Administration-approved daily Wegovy pill by Novo Nordisk (NVO) into its weight health GLP-1 platform.

The addition of the oral medication provides an alternative to injectable treatments for members seeking clinically supported options.

Participants in the Weight Watchers Med+ program can obtain the oral medication starting at $149 per month.

The integrated service model pairs the medication with behavioral coaching and digital tools intended to manage side effects and improve results, according to the company.

Shares of WW International were up more than 5% in recent trading.

Price: 33.10, Change: +1.66, Percent Change: +5.28

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10